Charles Schwab’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.95M | Buy |
640,249
+25,862
| +4% | +$241K | ﹤0.01% | 2257 |
|
2025
Q1 | $4.13M | Buy |
614,387
+157,135
| +34% | +$1.06M | ﹤0.01% | 2347 |
|
2024
Q4 | $4.86M | Buy |
457,252
+14,775
| +3% | +$157K | ﹤0.01% | 2347 |
|
2024
Q3 | $6.47M | Buy |
442,477
+302,916
| +217% | +$4.43M | ﹤0.01% | 2242 |
|
2024
Q2 | $1.69M | Buy |
139,561
+121,585
| +676% | +$1.47M | ﹤0.01% | 2756 |
|
2024
Q1 | $444K | Buy |
+17,976
| New | +$444K | ﹤0.01% | 3073 |
|